Failure of BE in fasting studies [Study As­sess­ment]

posted by drgunasakaran1  – 2012-10-09 22:07 (5009 d 15:51 ago) – Posting: # 9364
Views: 12,435

Dear Mr ABE,
It may be due to the variable absorption of the drug under fasting conditions. Sometimes, food enhances the absorption of the molecule and its pharmacokinetic parameters will show less variations under fed conditions. In these cases, the formulation will pass under fed conditions, but will fail in fasting study.
In these cases, it is better to do a pilot study in Fasting condition first, if the literature shows high variability and lesser absorption under fasting condition. If the formulation passes in Fasting condition, then it has higher chances of passing under Fed condition.
Say for example, if the formulation shows highly variable nature under fasting conditions, doing a routine two period, two way, cross over design is not going to help. You need to change your design to a Replicate design so that the formulation passes under fasting condition too.
In the above scenario, I will suggest you to go for Replicate design for Fasting study and Two period, Two way, Cross over under Fed conditions.

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
276 visitors (0 registered, 276 guests [including 15 identified bots]).
Forum time: 13:58 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5